(lp0
S'Discovery Labs Changes Name to Windtree Therapeutics, Inc.  PR Newswire  - Apr 18, 2016 WARRINGTON, Pa., April 18, 2016 /PRNewswire/ -- Discovery Laboratories, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has changed its&nbsp;...Bucks biotech firm changes its name - Philadelphia Business Journal'
p1
aS"Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation ... PR Newswire  - Feb 16, 2017 WARRINGTON, Pa., Feb. 16, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focusing on developing aerosolized KL4 surfactant therapies for respiratory diseases, announced today that data from a preclinical&nbsp;..."
p2
aS'Windtree Therapeutics Announces FDA Fast Track Designation for AEROSURF PR Newswire  - Sep 19, 2016 WARRINGTON, Pa., Sept. 19, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that the U.S.'
p3
aS'Windtree Therapeutics to Host a Conference Call and Webcast at 8:00 AM on ... PR Newswire  - Feb 15, 2017 WARRINGTON, Pa., Feb. 15, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, will host a conference call and webcast&nbsp;...'
p4
aS'Buy Windtree Therapeutics For Its Innovative AEROSURF Technology. Seeking Alpha - May 3, 2016 In this article, we are initiating coverage on Windtree Therapeutics , , a company that is focused on its proprietary synthetic surfactant  that is delivered non-invasively using novel ...'
p5
aS"Windtree Therapeutics' AEROSURF  Phase 2a Data ... PR Newswire  - Nov 28, 2016 WARRINGTON, Pa., Nov. 28, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced the Company's previously&nbsp;..."
p6
aS'Windtree Therapeutics Preclinical Study Results Show Potential for KL4 ... PR Newswire  - Nov 3, 2016 3, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. , a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, announced today that recently presented preclinical data at the 62nd&nbsp;...'
p7
aS"Windtree Therapeutics Inc  Given Consensus Rating of  by Brokerages The Cerbat Gem - Mar 27, 2017 Windtree Therapeutics logo Windtree Therapeutics Inc  has been assigned an average broker rating score of 0.00  from the two brokers that cover the company, Zacks Investment Research reports.Windtree Therapeutics, Inc.'s , a stock from Biotechnology Industry, has ... - Street Updates"
p8
aS'Windtree Therapeutics, Inc.  Files An 8-K Other Events Market Exclusive - Feb 16, 2017 On February 16, 2017, Windtree Therapeutics, Inc.  will host a conference call and live webcast at 8:00 a.m.'
p9
aS'Market Scope: Taking a Look at Windtree Therapeutics, Inc.  SKV News - 4 hours ago Checking in on shares of Windtree Therapeutics, Inc. , the stock currently has a Value Composite Score of 100.'
p10
a.